{"entity":{"id":"robyn-ward","kind":"person","name":"Robyn Ward","aka":[],"tldr":"Medical oncologist and cancer geneticist who chairs the independent expert committee that recommends which medicines Australia subsidises through the Pharmaceutical Benefits Scheme.","summary":"Professor Robyn Ward AM is Chair of the Pharmaceutical Benefits Advisory Committee (PBAC), the independent expert body appointed by the Australian Government to recommend new medicines for listing on the Pharmaceutical Benefits Scheme. She is Deputy Vice-Chancellor (Research and Enterprise) and Senior Vice-President of Monash University. Her expertise spans medical oncology, cancer genetics and health technology assessment, and she was made a Member of the Order of Australia for service to medical research and patient care in oncology.","asOf":"2026-09-10","links":[{"label":"Source: PBAC membership page","url":"https://www.pbs.gov.au/info/industry/listing/participants/pbac"}],"tags":["leadership","clinician-scientist","health-technology-assessment","drug-reimbursement"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["pbac"],"pathways":[],"terms":["hta"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Chair of the Pharmaceutical Benefits Advisory Committee","institutionId":"pbac","specialisms":["Medical oncology","Cancer genetics","Health technology assessment"],"profiles":[{"label":"PBAC membership page","url":"https://www.pbs.gov.au/info/industry/listing/participants/pbac"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ward+RL%5BAuthor%5D"}],"papers":[{"title":"Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study","journal":"PLOS ONE","year":2017,"doi":"10.1371/journal.pone.0184360"},{"title":"Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry","journal":"Genetics in Medicine","year":2013,"doi":"10.1038/gim.2012.91"},{"title":"Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution","journal":"Cancer Discovery","year":2014,"doi":"10.1158/2159-8290.cd-13-0285"}],"orcid":"0000-0002-6877-8906"},"route":"/people/robyn-ward/","neighbours":{"institution":[{"id":"pbac","kind":"institution","name":"Pharmaceutical Benefits Advisory Committee","route":"/institutions/pbac/"}],"term":[{"id":"hta","kind":"term","name":"Health technology assessment (HTA), reimbursement and QALYs","route":"/terms/hta/"}]}}